• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阵发性夜间血红蛋白尿患者粒细胞中PIG-A转录本的异常情况。

Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria.

作者信息

Miyata T, Yamada N, Iida Y, Nishimura J, Takeda J, Kitani T, Kinoshita T

机构信息

Department of Immunoregulation, Osaka University, Japan.

出版信息

N Engl J Med. 1994 Jan 27;330(4):249-55. doi: 10.1056/NEJM199401273300404.

DOI:10.1056/NEJM199401273300404
PMID:8272086
Abstract

BACKGROUND

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired disorder in which there is a deficiency in the synthesis by hematopoietic cells of the glycosyl-phosphatidylinositol molecules that anchor proteins to the cell membrane. Recently, we demonstrated that a gene termed PIG-A (for phosphatidylinositol glycan class A), a component of glycosyl-phosphatidylinositol biosynthesis, was responsible for PNH in two patients. The present study was undertaken to elucidate whether PIG-A is the gene responsible for all cases of PNH and to characterize further the somatically acquired abnormalities of this gene.

METHODS

We studied granulocytes from 15 patients with PNH. The cell content of CD55 and CD59 was assessed by fluorescence-activated flow cytometry. PIG-A transcripts were reverse-transcribed, amplified by the polymerase chain reaction, and cloned into plasmids. The structure of the cloned complementary DNA was analyzed by nucleotide sequencing, and its function was assessed on the basis of its ability to restore to normal the abnormal phenotype of a PIG-A-deficient cell line after transfection.

RESULTS

Three patients had size abnormalities of PIG-A transcripts with different patterns, and in one patient a very low level of the PIG-A transcript was found. Eleven patients had transcripts of normal size, but the transfection assay revealed that in each patient some of them were nonfunctional. The percentage of nonfunctional PIG-A transcripts was correlated with the percentage of affected granulocytes (P < 0.001). Sequence analysis demonstrated somatic mutations in two of the patients.

CONCLUSIONS

PIG-A is the gene responsible for PNH in all patients studied to date.

摘要

背景

阵发性睡眠性血红蛋白尿症(PNH)是一种获得性疾病,造血细胞合成将蛋白质锚定到细胞膜的糖基磷脂酰肌醇分子存在缺陷。最近,我们证明了一个名为PIG - A(磷脂酰肌醇聚糖A类)的基因,作为糖基磷脂酰肌醇生物合成的一个组成部分,是两名患者PNH的病因。本研究旨在阐明PIG - A是否是所有PNH病例的致病基因,并进一步表征该基因体细胞获得性异常情况。

方法

我们研究了15例PNH患者的粒细胞。通过荧光激活流式细胞术评估CD55和CD59的细胞含量。PIG - A转录本进行逆转录,通过聚合酶链反应扩增,并克隆到质粒中。通过核苷酸测序分析克隆的互补DNA的结构,并根据其转染后恢复PIG - A缺陷细胞系异常表型至正常的能力评估其功能。

结果

3例患者的PIG - A转录本存在不同模式的大小异常,1例患者发现PIG - A转录本水平极低。11例患者的转录本大小正常,但转染试验显示,每位患者中一些转录本无功能。无功能PIG - A转录本的百分比与受影响粒细胞的百分比相关(P < 0.001)。序列分析显示2例患者存在体细胞突变。

结论

PIG - A是迄今为止所有研究患者PNH的致病基因。

相似文献

1
Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿患者粒细胞中PIG-A转录本的异常情况。
N Engl J Med. 1994 Jan 27;330(4):249-55. doi: 10.1056/NEJM199401273300404.
2
PIG-A gene abnormalities in Thai patients with paroxysmal nocturnal hemoglobinuria.泰国阵发性夜间血红蛋白尿患者的PIG-A基因异常
Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:322-4.
3
Genotypic and phenotypic implications in paroxysmal nocturnal hemoglobinuria (PNH): a preliminary investigation.阵发性睡眠性血红蛋白尿症(PNH)的基因型和表型影响:一项初步研究。
Southeast Asian J Trop Med Public Health. 1997;28 Suppl 3:58-63.
4
A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.再生障碍性贫血患者阵发性夜间血红蛋白尿克隆性质及PIG-A突变的队列研究。
Eur J Haematol. 2006 Jun;76(6):502-9. doi: 10.1111/j.0902-4441.2005.t01-1-EJH2467.x. Epub 2006 Mar 9.
5
[Recent advances in research on paroxysmal nocturnal hemoglobinuria].[阵发性夜间血红蛋白尿的研究新进展]
Rinsho Ketsueki. 1993 May;34(5):529-36.
6
Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria.泰国阵发性夜间血红蛋白尿患者的基因型、免疫表型及临床特征
Br J Haematol. 1999 May;105(2):497-504.
7
The distribution of PIG-A gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts.阵发性夜间血红蛋白尿症粒细胞和培养的成红细胞中PIG-A基因异常的分布情况。
Exp Hematol. 2001 Apr;29(4):391-400. doi: 10.1016/s0301-472x(00)00684-6.
8
Paroxysmal nocturnal hemoglobinuria: the price for a chance.阵发性夜间血红蛋白尿:机会的代价。
Schweiz Med Wochenschr. 1996 Nov 9;126(45):1912-21.
9
Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症中基因不稳定性及体细胞PIG-A突变的病因学
Blood Cells Mol Dis. 1999 Apr;25(2):81-91. doi: 10.1006/bcmd.1999.0229.
10
Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.阵发性夜间血红蛋白尿:分子发病机制与分子治疗方法
Hematopathol Mol Hematol. 1998;11(3-4):119-46.

引用本文的文献

1
Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.超越抗体回收:克拉利单抗的分子设计使 PNH 治疗可实现每四周一次皮下注射。
Int J Mol Sci. 2024 Oct 30;25(21):11679. doi: 10.3390/ijms252111679.
2
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment.阵发性夜间血红蛋白尿症、病理生理学、诊断与治疗
Transfus Med Hemother. 2024 Aug 21;51(5):310-320. doi: 10.1159/000540474. eCollection 2024 Oct.
3
Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond?
骨髓衰竭性疾病的诊断评估:在 2024 年及以后,我们有哪些新的认识来帮助我们做出移植决策?
Bone Marrow Transplant. 2024 Apr;59(4):444-450. doi: 10.1038/s41409-024-02213-6. Epub 2024 Jan 30.
4
A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?阵发性夜间血红蛋白尿治疗前景综述:我们现在所处的位置以及未来的发展方向?
Ther Adv Rare Dis. 2020 Oct 22;1:2633004020959349. doi: 10.1177/2633004020959349. eCollection 2020 Jan-Dec.
5
The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target.阵发性睡眠性血红蛋白尿症中的补体替代途径:从发病机制到治疗靶点。
Immunol Rev. 2023 Jan;313(1):262-278. doi: 10.1111/imr.13137. Epub 2022 Sep 15.
6
How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.我们将如何治疗阵发性睡眠性血红蛋白尿症:深入未来。
Br J Haematol. 2022 Jan;196(2):288-303. doi: 10.1111/bjh.17753. Epub 2021 Aug 5.
7
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria.达尼可泮:一种用于阵发性夜间血红蛋白尿的口服补体因子 D 抑制剂。
Haematologica. 2021 Dec 1;106(12):3188-3197. doi: 10.3324/haematol.2020.261826.
8
The impact of missense mutation in PIGA associated to paroxysmal nocturnal hemoglobinuria and multiple congenital anomalies-hypotonia-seizures syndrome 2: A computational study.与阵发性夜间血红蛋白尿和多重先天性异常-低张力-癫痫综合征2相关的PIGA基因错义突变的影响:一项计算研究
Heliyon. 2019 Oct 23;5(10):e02709. doi: 10.1016/j.heliyon.2019.e02709. eCollection 2019 Oct.
9
Novel insights into the treatment of complement-mediated hemolytic anemias.补体介导的溶血性贫血治疗的新见解。
Ther Adv Hematol. 2019 Sep 9;10:2040620719873321. doi: 10.1177/2040620719873321. eCollection 2019.
10
Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.抗补体治疗阵发性睡眠性血红蛋白尿症:是否需要近端补体抑制?来自 EBMT 的 SAAWP 的立场文件。
Front Immunol. 2019 Jun 14;10:1157. doi: 10.3389/fimmu.2019.01157. eCollection 2019.